Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H22N4O2 |
Molecular Weight | 374.4357 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OC(=O)N[C@@H]1CC2=C(C1)C3=C(C=CC(=C3)C#N)N2CC4=CC=CC=N4
InChI
InChIKey=IHIWYQYVBNODSV-KRWDZBQOSA-N
InChI=1S/C22H22N4O2/c1-14(2)28-22(27)25-17-10-19-18-9-15(12-23)6-7-20(18)26(21(19)11-17)13-16-5-3-4-8-24-16/h3-9,14,17H,10-11,13H2,1-2H3,(H,25,27)/t17-/m0/s1
Molecular Formula | C22H22N4O2 |
Molecular Weight | 374.4357 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 03:21:10 UTC 2023
by
admin
on
Sat Dec 16 03:21:10 UTC 2023
|
Record UNII |
XKW9MYF94Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C123792
Created by
admin on Sat Dec 16 03:21:10 UTC 2023 , Edited by admin on Sat Dec 16 03:21:10 UTC 2023
|
PRIMARY | |||
|
100000175545
Created by
admin on Sat Dec 16 03:21:10 UTC 2023 , Edited by admin on Sat Dec 16 03:21:10 UTC 2023
|
PRIMARY | |||
|
24963749
Created by
admin on Sat Dec 16 03:21:10 UTC 2023 , Edited by admin on Sat Dec 16 03:21:10 UTC 2023
|
PRIMARY | |||
|
1029692-15-6
Created by
admin on Sat Dec 16 03:21:10 UTC 2023 , Edited by admin on Sat Dec 16 03:21:10 UTC 2023
|
PRIMARY | |||
|
CHEMBL3542265
Created by
admin on Sat Dec 16 03:21:10 UTC 2023 , Edited by admin on Sat Dec 16 03:21:10 UTC 2023
|
PRIMARY | |||
|
XKW9MYF94Y
Created by
admin on Sat Dec 16 03:21:10 UTC 2023 , Edited by admin on Sat Dec 16 03:21:10 UTC 2023
|
PRIMARY | |||
|
DTXSID50145591
Created by
admin on Sat Dec 16 03:21:10 UTC 2023 , Edited by admin on Sat Dec 16 03:21:10 UTC 2023
|
PRIMARY | |||
|
DB12573
Created by
admin on Sat Dec 16 03:21:10 UTC 2023 , Edited by admin on Sat Dec 16 03:21:10 UTC 2023
|
PRIMARY | |||
|
LY-2452473
Created by
admin on Sat Dec 16 03:21:10 UTC 2023 , Edited by admin on Sat Dec 16 03:21:10 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
After normalization for hepatic content of the contributing P450s, CYP3A4 was the largest contributor (68%) to substrate depletion, suggesting a major role of CYP3A4 in the hepatic clearance of LY2452473.
MAJOR
|
||
|
TARGET -> AGONIST |
SARM
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
. CYP2J2 showed the second largest contribution to substrate depletion (15%) after normalization for hepatic content
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
FECAL; URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
FECAL; URINE
|
||
|
METABOLITE -> PARENT |
MAJOR
PLASMA
|
||
|
METABOLITE -> PARENT |
FECAL; PLASMA; URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
|
|||